PortfoliosLab logoPortfoliosLab logo
FIAC vs. TCRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FIAC vs. TCRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Focus Impact Acquisition Corp. (FIAC) and TScan Therapeutics, Inc. (TCRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


FIAC

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

TCRX

1D
6.46%
1M
-13.11%
YTD
-7.90%
6M
1.13%
1Y
-36.48%
3Y*
-30.13%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FIAC vs. TCRX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
FIAC
Focus Impact Acquisition Corp.
0.00%0.00%-81.54%6.97%3.14%1.23%
TCRX
TScan Therapeutics, Inc.
-7.90%-67.11%-47.86%276.13%-65.56%-8.72%

Correlation

The correlation between FIAC and TCRX is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (3Y)
Calculated over the trailing 3-year period

0.00

Correlation (All Time)
Calculated using the full available price history since Dec 23, 2021

-0.00

Fundamentals

Market Cap

FIAC:

$19.53M

TCRX:

$119.65M

EPS

FIAC:

-$1.26

TCRX:

-$0.96

PS Ratio

FIAC:

552.51

TCRX:

14.67

Total Revenue (TTM)

FIAC:

$19.03K

TCRX:

$8.15M

Gross Profit (TTM)

FIAC:

$6.16K

TCRX:

$6.66M

EBITDA (TTM)

FIAC:

-$7.52M

TCRX:

-$129.32M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FIAC vs. TCRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FIAC

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


TCRX
TCRX Risk / Return Rank: 2626
Overall Rank
TCRX Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
TCRX Sortino Ratio Rank: 2929
Sortino Ratio Rank
TCRX Omega Ratio Rank: 2929
Omega Ratio Rank
TCRX Calmar Ratio Rank: 2323
Calmar Ratio Rank
TCRX Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FIAC vs. TCRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Focus Impact Acquisition Corp. (FIAC) and TScan Therapeutics, Inc. (TCRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FIACTCRXDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.99

Calmar ratioReturn relative to maximum drawdown

-0.55

Martin ratioReturn relative to average drawdown

-0.79

FIAC vs. TCRX - Sharpe Ratio Comparison


Loading charts...

Drawdowns

FIAC vs. TCRX - Drawdown Comparison


Loading charts...

Drawdown Indicators


FIACTCRXDifference

Max Drawdown

Largest peak-to-trough decline

-93.71%

Max Drawdown (1Y)

Largest decline over 1 year

-66.35%

Max Drawdown (3Y)

Largest decline over 3 years

-91.08%

Current Drawdown

Current decline from peak

-93.17%

Average Drawdown

Average peak-to-trough decline

-72.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.35%

Volatility

FIAC vs. TCRX - Volatility Comparison


Loading charts...

Volatility by Period


FIACTCRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.61%

Volatility (6M)

Calculated over the trailing 6-month period

51.24%

Volatility (1Y)

Calculated over the trailing 1-year period

86.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

98.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

98.15%

Dividends

FIAC vs. TCRX - Dividend Comparison

Neither FIAC nor TCRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

FIAC vs. TCRX - Financials Comparison

This section allows you to compare key financial metrics between Focus Impact Acquisition Corp. and TScan Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00M4.00M6.00M8.00M20222023202420252026
720.00
0
(FIAC) Total Revenue
(TCRX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


FIAC and TCRX have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for FIAC and TCRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer